asciminib
Showing 1 - 12 of 12
Chronic Myeloid Leukemia Trial (Asciminib)
Available
- Chronic Myeloid Leukemia
- Asciminib
- (no location specified)
Jan 17, 2023
Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- +3 more
- Asciminib
- Ascimininb + Nilotinib
-
Augusta, Georgia
- +1 more
Jul 14, 2022
Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)
Not yet recruiting
- Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
- Asciminib
- Imatinib
- (no location specified)
Jun 7, 2022
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)
Not yet recruiting
- Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
- Asciminib
- Nilotinib
- (no location specified)
Jul 11, 2022
Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)
Recruiting
- Leukemia, Chronic Myelogenous
- asciminib
- best available treatment
-
Chongqing City, Chongqing, China
- +23 more
Jan 18, 2023
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)
Recruiting
- Chronic Myelogenous Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Asciminib single agent
- +5 more
-
Ann Arbor, Michigan
- +49 more
Jan 26, 2023
Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- Asciminib
- Imatinib
-
Detroit, Michigan
- +1 more
May 3, 2022
Renal Impairment Trial in Sofia, Berlin (Asciminib)
Completed
- Renal Impairment
- Asciminib
-
Sofia, Bulgaria
- +1 more
Oct 7, 2021
Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)
Recruiting
- Chronic Myelogenous Leukemia - Chronic Phase
- asciminib
-
Birmingham, Alabama
- +25 more
Jan 10, 2023
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)
Recruiting
- Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
- Asciminib
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)
Recruiting
- Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
- Imatinib
- +4 more
-
Longmont, Colorado
- +128 more
Aug 1, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Asciminib
- Bosutinib
-
Chicago, Illinois
- +87 more
Jan 20, 2023